Skip to main content
Premium Trial:

Request an Annual Quote

NIH Renews Sequencing Contract with Agencourt

NEW YORK, Aug 31 (GenomeWeb News) - The National Institutes of Health has renewed a contract with Agencourt Biosciences' genomic sequencing services for another two years, the company said today.

Under the renewed contract, Agencourt will continue to provide ESTs and SAGE sequencing for the Mammalian Gene Collection and Cancer Genome Anatomy projects at NIH. The original contract began in January 2002 and runs through the end of this year.

Agencourt said that it has so far sequenced more than 1.3 million cDNA ESTs for the MGC project, which is co-managed by the National Human Genome Research Institute and the National Cancer Institute.

Financial terms of the renewed contract were not provided.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.